These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 13410498)

  • 1. [Clinico-statistical and genetic research on neoplasms of the prostate].
    MORGANTI G; GIANFERRARI L; CRESSERI A; ARRIGONI G; LOVATI G
    Acta Genet Stat Med; 1956-1957; 6(2):304-5. PubMed ID: 13410498
    [No Abstract]   [Full Text] [Related]  

  • 2. [Five years of medical therapy of cancer of the prostate; clinico-statistical findings].
    ARRIGONI G; CHIEREGO F
    G Ital Chemioter; 1956; 3(3-4):575-7. PubMed ID: 13462212
    [No Abstract]   [Full Text] [Related]  

  • 3. [Genetic and clinico-statistical research on neoplasms of the prostate].
    GIANFERRARI L; ARRIGONI G; CRESSERI A; LOVATI G; MORGANTI G
    Acta Genet Med Gemellol (Roma); 1956 May; 5(2):224-33. PubMed ID: 13326203
    [No Abstract]   [Full Text] [Related]  

  • 4. Statistical dissection of genetic pathways involved in prostate carcinogenesis.
    Ribeiro FR; Diep CB; Jerónimo C; Henrique R; Lopes C; Eknaes M; Lingjaerde OC; Lothe RA; Teixeira MR
    Genes Chromosomes Cancer; 2006 Feb; 45(2):154-63. PubMed ID: 16235241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimized prostate biopsy via a statistical atlas of cancer spatial distribution.
    Shen D; Lao Z; Zeng J; Zhang W; Sesterhenn IA; Sun L; Moul JW; Herskovits EH; Fichtinger G; Davatzikos C
    Med Image Anal; 2004 Jun; 8(2):139-50. PubMed ID: 15063863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DISCUSSION ON EXPERIMENTAL TUMORS; THE IMMUNE STATE INVOLVED IN SUBCUTANEOUS IMPLANTS OF PROSTATIC TISSUE.
    BISHOP DW
    Natl Cancer Inst Monogr; 1963 Oct; 12():409-11. PubMed ID: 14073014
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinico-biological aspects of several cases of carcinoma of the prostate treated with polyestradiol phosphate (PEP)].
    MOLINATTI GM; OLIVETTI M
    Minerva Med; 1959 Mar; 50(21):745-50. PubMed ID: 13656687
    [No Abstract]   [Full Text] [Related]  

  • 8. Primary high grade sarcoma of the specialised prostatic stroma: a case report with clinico-pathological considerations.
    Fraggetta F; Pepe P; Giunta ML; Aragona F
    Pathologica; 2008 Dec; 100(6):482-4. PubMed ID: 19475893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The expanding role of epigenetics in the development, diagnosis and treatment of prostate cancer and benign prostatic hyperplasia.
    Dobosy JR; Roberts JL; Fu VX; Jarrard DF
    J Urol; 2007 Mar; 177(3):822-31. PubMed ID: 17296351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AIDIT and IMPACT: building research collaborations in targeted prostate cancer screening.
    Doherty R; Lubinski J; Manguoglu E; Luleci G; Christie M; Craven P; Bancroft E; Mitra A; Morgan S; Eeles R;
    J BUON; 2006; 11(4):415-8. PubMed ID: 17309171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular pathology of prostate cancer.
    Konishi N; Shimada K; Ishida E; Nakamura M
    Pathol Int; 2005 Sep; 55(9):531-9. PubMed ID: 16143027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathology of the prostate in radical cystectomy specimens: a critical review.
    Autorino R; Di Lorenzo G; Damiano R; Giannarini G; De Sio M; Cheng L; Montironi R
    Surg Oncol; 2009 Mar; 18(1):73-84. PubMed ID: 18760917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of inflammation and infection in the pathogenesis of prostate carcinoma.
    Wagenlehner FM; Elkahwaji JE; Algaba F; Bjerklund-Johansen T; Naber KG; Hartung R; Weidner W
    BJU Int; 2007 Oct; 100(4):733-7. PubMed ID: 17662075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of genetically engineered mouse models of prostate cancer for nutrition and cancer chemoprevention research.
    Klein RD
    Mutat Res; 2005 Aug; 576(1-2):111-9. PubMed ID: 15885713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammation and prostate cancer.
    Sugar LM
    Can J Urol; 2006 Feb; 13 Suppl 1():46-7. PubMed ID: 16526982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical interpretation of prostate biopsy reports.
    Parsons JK; Partin AW
    Urology; 2006 Mar; 67(3):452-7. PubMed ID: 16504268
    [No Abstract]   [Full Text] [Related]  

  • 17. Upregulation of erythropoietin receptor in human prostate carcinoma and high-grade prostatic intraepithelial neoplasia.
    Zhou T; Xu C; He M; Sun Y
    Prostate Cancer Prostatic Dis; 2008; 11(2):143-7. PubMed ID: 17637760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The 2008 European School of Oncology inside track conference, "predictive modeling in prostate cancer".
    Valdagni R; Scardino PT; Denis L
    Cancer; 2009 Jul; 115(13 Suppl):3035-8. PubMed ID: 19544554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate cancer in Maiduguri.
    Yawe KT; Tahir MB; Nggada HA
    West Afr J Med; 2006; 25(4):298-300. PubMed ID: 17402521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HISTOCHEMISTRY OF SOME ASPECTS OF PROSTATE PATHOLOGY.
    BRANDES D; BOURNE GH
    Natl Cancer Inst Monogr; 1963 Oct; 12():29-41. PubMed ID: 14073001
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.